Regeneron Pharmaceuticals, Inc. (REGN) Profit Margins
Over the twelve months to 2026-06-30, Regeneron Pharmaceuticals, Inc. (REGN) had operating margin 24.7%, net margin 27.9%, free cash flow margin 24.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
REGNRegeneron Pharmaceuticals, Inc.Follow REGN — free
—
Price chart with a free account
- Market cap
- 82.9B
- P/E TTM
- 19.9
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 30 Oct, in 6 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 99.5% | 99.1% | 93.9% | 94.4% | 95.4% | 94.1% | 96.0% | 96.6% | — | 93.9% | — | — | — | — | — | — | — | |
| Operating margin | -21.2% | -46.0% | 33.2% | 35.3% | 29.2% | 30.5% | 27.4% | 35.4% | 49.3% | 33.7% | 42.1% | 55.7% | 38.9% | 30.9% | 28.1% | 24.9% | 24.7% | |
| Net margin | -22.8% | -49.7% | 54.4% | 19.7% | 12.0% | 15.5% | 18.4% | 20.4% | 47.5% | 32.3% | 41.3% | 50.2% | 35.6% | 30.1% | 31.1% | 31.4% | 27.9% | |
| FCF margin | -0.1% | -44.6% | -9.0% | 20.5% | 14.9% | 15.9% | 20.0% | 17.6% | 35.2% | 30.5% | 23.6% | 40.6% | 36.3% | 29.5% | 25.8% | 28.4% | 24.2% |
USD billions · SEC XBRL
Regeneron Pharmaceuticals, Inc. — questions
- What is Regeneron Pharmaceuticals, Inc.'s operating margin?
- 24.7% over the twelve months to 2026-06-30.
- What is Regeneron Pharmaceuticals, Inc.'s net profit margin?
- 27.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Regeneron Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.